ESR1 and breast carcinoma: Previously, SLC6A14 expression has been reported to be correlated with the estrogen receptor (ER) status [16], however we did not find a significant correlation between the two variables in the tested breast cancer cell lines (P-value = 0.1274, Mann-Whitney U test) or in the breast tumors (Supplementary Figure 1A).